CYP2B6 Polymorphisms in Ketamine
Brief Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | Has Results |
| Age: | 18 Years to 50 Years (Adult) |
| Enrollment: | 30 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Nov 13, 2022 | |
|---|---|---|
| Primary Completion: | May 16, 2022 | |
| Completion Date: | May 17, 2022 | |
| Study First Posted: | Nov 20, 2013 | |
| Results First Posted: | May 18, 2018 | |
| Last Updated: | May 18, 2018 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 50 |
More Details
| NCT Number: | NCT01988922 |
|---|---|
| Other IDs: | 201307034 |
| Study URL: | https://ClinicalTrials.gov/show/NCT01988922 |
Last updated: Jun 17, 2022